Respiratory

Patient Reported Outcomes

BCSS (The Breathlessness, Cough and Sputum Scale)

The Breathlessness, Cough and Sputum Scale (BCSS) is a patient-reported outcome measure to evaluate symptoms in patients with chronic obstructive pulmonary disease (COPD). The BCSS is a daily diary that asks patients to rate the severity of the three symptoms, each on a 5-point scale; higher scores indicate more severe symptoms. Item scores are summed to yield a total score.

  • Developed and used for diary card and eDiary administration
  • Takes approx 1-2 minutes to complete
  • Recall period is “today”, to be completed in the evening
  • Each item is rated on a 5-point Likert scale
  • Developed for adult patients with a COPD disease

References:

Leidy, N.K., et. al. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale ©. Respiratory Medicine. 2003; 97(Suppl A):S59–S70

Leidy, N.K., et. al. The Breathlessness, Cough and Sputum Scale ©: The Development of Empirically Based Guidelines for Interpretation. Chest, 2003, 124:2182–2191

MASQ (Morning Activity and Symptoms Questionnaire)

Morning Activity and Symptoms Questionnaire (MASQ) is a patient-reported outcome instrument developed to measure morning activities and morning symptoms. The MASQ consist of two parts that captures instant symptoms through the Global Chest Symptoms Questionnaire (GCSQ), and morning activities through the Capacity of Daily Living during the morning (CDLM) questionnaire. The MASQ was developed as an eDiary to be assessed in the morning, and for the CDLM after morning activities have been completed.

  • Developed for eDiary administration
  • Takes approx 3-5 minutes to complete
  • Recall period is since “right now” for the GCSQ and “this morning” for the CDLM.
  • Each item is rated on a 5 point Likert scale
  • Developed for adult patients with a COPD disease

References:

Partridge MR, Karlsson, N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009; 25: 2043-2048

Partridge MR, Miravitlles M, Ståhl E, Karlsson N, Svensson K, Welte T. Development and validation of the Capacity of Daily Living During the Morning and Global Chest Symptoms Questionnaires in COPD. Eur Resp J 2010; 36: 96-104

CDLM (Capacity of Daily Living during the Morning)

The Capacity of Daily Living During the Morning (CDLM) is a patient-reported outcome instrument developed to measure ability to perform basic morning activities. The CDLM was developed as part of the MASQ, and can be used as a standalone measure of morning activities. The CDLM was developed as an eDiary to be assessed in the morning, after morning activities have been completed.

  • Developed for eDiary administration
  • Takes approx 2-4 minutes to complete
  • Recall period is “this morning”.
  • Each item is rated on a 5 point Likert scale
  • Developed for adult patients with a COPD disease

References:

Partridge MR, Karlsson, N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009; 25: 2043-2048

Partridge MR, Miravitlles M, Ståhl E, Karlsson N, Svensson K, Welte T. Development and validation of the Capacity of Daily Living During the Morning and Global Chest Symptoms Questionnaires in COPD. Eur Resp J 2010; 36: 96-104

Downloads